Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Aesica Introduces New Service Model | Contract Pharma

What are you searching for?

Sign in
Breaking News

Aesica Introduces New Service Model

Aims to simplify supply chain management

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Aesica has introduced a new service model aimed at solving multiple supply chain challenges, under which the company will take on the management of other CDMOs, while serving as the single point of customer contact.
 
This model allows Aesica to reduce the number of CDMOs the customer previously had to manage, and identify the most strategically useful and effective CDMOs to engage in projects.The service aims to streamline processes and create a simplified supply chain structure, reducing the overall number of supplier relationships, while maintaining a consistent outsourcing approach across an entire portfolio. It is also designed to optimize efficiency, eliminate waste and supply shortages, and to achieve cost savings.
 
Aesica currently manages a portfolio of more than 10 different CDMOs and has a dedicated team responsible for ensuring total process management across an entire supply chain. This includes procurement to manage the relationship, risk assessment and price negotiations between customers, Aesica and the other CDMOs, as well as manage QC and QA activities.
 
The model is primarily geared to small and medium sized CDMOs, facing the same price pressures as big pharma, while lacking all the resources required for managing multiple CDMOs. It is also suited to companies that have diverse portfolios with affiliates or licensees based across multiple geographic regions.
  
Garry Hodges, operations director, Aesica Pharmaceuticals said, “We are very pleased to have brought our new business model to the market to help meet the pressing demand from the pharma market for solutions that improve, streamline and significantly simplify their supply chains. Our business model helps our customers to lower their costs, reduce risk and to be faster to market.” 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics